Latest Auro Laboratories stock price
Auro Laboratories P/E Ratio
AUROLAB • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
96.22
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
96.22
Current Price
₹283.85
EPS (TTM)
₹2.95
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
49.33
Sector Median
26.63
Sector Rank
#11 of 140
Sector Percentile
7.9%
Earnings Breakdown (TTM)
TTM EPS
₹2.76
Sept 2025
₹1.15
Jun 2025
₹-0.17
Key P/E Ratio Insights for Auro Laboratories
- Stock appears overvalued with PE of 96.22, suggesting caution for new investments
- Trading at premium to sector average PE of 49.33
View the AUROLAB equity price for detailed stock performance.
Related Pages for Auro Laboratories
Additional stock information and data for AUROLAB
Sector P/E Ratio Comparison
Comparing Auro Laboratories with other companies in Healthcare sector
Sector Average
49.33
Sector Median
26.63
Lowest P/E
0.97
Highest P/E
993.26
Companies
140
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 3.0 | ₹43 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.67 | ₹1,166 | Low |
| Medicamen Organics | MEDIORG | 6.33 | ₹26 | Low |
| Amwill Health Care | AMWILL | 6.53 | ₹70 | Low |
| Galaxy Medicare | GML | 7.25 | ₹24 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.74 | ₹2,188 | Low |
| Zenith Drugs | ZENITHDRUG | 7.9 | ₹76 | Low |
| Brooks Laboratories | BROOKS | 8.01 | ₹184 | Low |
| Vasundhara Rasayans | VRL | 9.97 | ₹37 | Low |